Authors
Latest:
Medicare Part D Optimization: Potential Out-of-Pocket Savings Through Plan ReexaminationMedicare Part D plans can change their cost-sharing structure and formularies every year. As such, beneficiaries should annually reevaluate plan offerings to minimize their out-of-pocket costs.
Latest:
Impact of Antidepressant Therapy on Statin Adherence and Cholesterol ControlAmong patients with poor statin adherence, adequate antidepressant treatment significantly improved adherence and persistence compared with inadequate or no antidepressant treatment.
Latest:
Comparative Treatment Patterns Among Psoriasis Patients Using Adalimumab, Etanercept, or UstekinumabThis retrospective study compared the treatment patterns of ustekinumab with recommended maintenance administration every 12 weeks, with adalimumab and etanercept, administered weekly or every other week, for the treatment of plaque psoriasis.
Latest:
Organ Transplant-Specialized Pharmacies: Providing Patient Care to Improve Adherence and OutcomesOrgan transplant patients face unique challenges and can benefit from the support of a specialized pharmacy team.
Latest:
Antidepressant Discontinuation: What the Tertiary Databases and Package Insert Tells YouDiscontinuation of antidepressants should take place gradually, as abrupt stoppage or marked reduction in the dosage of an antidepressant is frequently associated with adverse effects (AEs), such as withdrawal symptoms.
Latest:
Functional Gastrointestinal DisordersIn 2013, a CDC study reported that gastrointestinal (GI)-related dysfunction was responsible for 13,011 annual outpatient office visits.
Latest:
The New Compounding Law and Community Pharmacy's FutureMeaningful federal compounding legislation has been developed.
Latest:
Is it Time to Take Another Look at Retail at Specialty Pharmacy?The concept of specialty at retail has the potential to unlock vast financial, contracted volume, and patient continuum of care opportunities attached to pharmaceutical products currently dispensed in specialty pharmacies.
Latest:
Rx Product News: Profile: A Closer Look at New FDA Actions: AmitizaThe FDA recently approved Amitiza for the treatment of irritable bowel syndrome with constipation in women aged 18 years and older.
Latest:
The Pharmacist’s Role: Opioid-related Risks With a Psychiatric DrugPharmacists dispensing Lybalvi should understand that potentially life-threatening consequences can occur if opioids are taken concurrently.
Latest:
Smart Bottles: Implementation ConsiderationsWhat to consider when considering a smart bottle program.
Latest:
Reactions to Pharmacy Times Health-System EditionStephen F. Eckel, PharmD, MHA, Pharmacy Times Health-System Edition editor discusses the overall reactions he has heard surrounding Pharmacy Times Health-System Edition.
Latest:
The Backup Pharmacist-in-Charge: The Growing Importance to Specialty PharmacyProper succession planning for your pharmacist-in-charge is a must for continuity of business.
Latest:
Revisiting "Right to Try" LegislationIn summer 2016, Pharmacy Times® published an article titled “‘Right to Try’ Legislation: A Developing Legal Issue Related to Medications” that discussed the basics of a popular health policy issue.
Latest:
Travel Immunization in the Pharmacy: Exploring the Growing OpportunityUS citizens are increasingly traveling to international destinations, with Americans making 38 million visits abroad in 2017. Fortunately, pharmacists are well-placed to assist patients in their travel health needs.
Latest:
New FDA Actions: UCB's NeuproThe FDA approved Neupro (Rotigotine Transdermal System) for the treatment of Parkinson's disease and restless leg syndrome.
Latest:
CDC: Many Pre-Pandemic Activities Can Resume for Fully Vaccinated IndividualsThe agency also advised that fully vaccinated individuals can resume many activities without wearing a mask or social distancing.
Latest:
Think Outside the Box for Front-End Profit Opportunities in the PharmacyTaking steps to improve front-end sales takes some time and out-of-the-box thinking, but it can prove profitable and improve word-of-mouth recommendations.
Latest:
A Computerized Asthma Outcomes Measure Is Feasible for Disease ManagementThe ASTHMA-CAT, an online, patient-based assessment measure, may facilitate asthma care management.
Latest:
Cost-Effectiveness of Docetaxel-Cyclophosphamide Versus Doxorubicin-Cyclophosphamide for Breast CancerCompared with doxorubicin plus cyclophosphamide, docetaxel plus cyclophosphamide was highly cost-effective for adjuvant treatment of operable breast cancer.
Latest:
Hepatitis C Case Study at Prosperity Specialty PharmacyAdherence for targeted therapies is even more essential now than it ever has been. This case study of services offered at a specialty pharmacy illustrates the impact of hepatitis C patients.
Latest:
Daily Dose and Costs of Therapy With Topical Testosterone AgentsWe assessed time to maintenance dose attainment in commercially insured men initiating topical testosterone agents and compared daily maintenance doses and costs of this therapy.
Latest:
Assessing the Impact of Patient Assistance Programs on Financial Toxicity in Oral OncologyPAPs can significantly reduce OOP costs for patients.
